Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06559059

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Led by NYU Langone Health · Updated on 2026-06-03

1800

Participants Needed

5

Research Sites

8 weeks

Total Duration

On this page

Sponsors

N

NYU Langone Health

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the VA National TeleOncology program (NTO), a multilevel telehealth population health management program, among Veterans diagnosed with lung, colorectal, prostate, or breast cancers. The study focuses on assessing the program's effectiveness in increasing telehealth engagement, improving clinical quality, and managing healthcare costs across different patient characteristics. The study compares two groups: Veterans receiving oncology care through the NTO telehealth service and those receiving usual in-person care at VA medical centers without NTO. The NTO program offers medical and subspecialty oncology care remotely via telehealth between VA facilities as an alternative to community or in-person visits. Providers and staff involved in cancer care at these VA centers are also included. Participants' medical records will be reviewed to observe telehealth visit frequency, clinical quality measures such as the Quality Oncology Practice Initiative (QOPI) score, timeliness of appointments and treatments, and overall healthcare costs up to three months after NTO implementation. The study uses VA health information systems to identify eligible patients and providers and analyze outcomes based on telehealth use and usual care. The study started in June 2024 and is expected to continue until July 2027.

CONDITIONS

Brief Title

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be a Veteran
  • Be aged 18 years or older
  • Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit
  • Have had an oncology visit during the past 36 months at a Veterans Affairs Medical Center (VAMC) location
  • Be a provider or staff member at a VAMC involved in cancer care
  • Providers or staff must have cared for at least 5 Veterans with cancer in the past 6 months at a VAMC location
Not Eligible

You will not qualify if you...

  • Veterans who have not seen any VA providers in the past year
  • Patients with a previous diagnosis of lung, prostate, breast, or colon cancer
  • Pregnant patients
  • Providers or staff who do not treat Veterans with the specified cancers in oncology at the VA

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Outpatient Treatment

Duration - Up to 3 months

Participants receive oncology care through the VA National TeleOncology Service (NTO) via telehealth visits as an alternative to usual in-person care.

Telehealth visits during this period

Trial Site Locations

Total: 5 locations

1

VA New York Harbor Healthcare System - Brooklyn

Brooklyn, New York, United States, 11209

Actively Recruiting

2

VA New York Harbor Healthcare System - St. Albans Community Living Center

Jamaica, New York, United States, 11425

Actively Recruiting

3

VA New York Harbor Health Care System - Manhattan

New York, New York, United States, 10010

Actively Recruiting

4

VA New York Harbor Healthcare System - Harlem Community Center

New York, New York, United States, 10027

Actively Recruiting

5

VA New York Harbor Healthcare System - Staten Island Community Clinic

Staten Island, New York, United States, 10314

Actively Recruiting

Loading map...

Research Team

J

Janeth Juarez Padilla

N

Navid Dardashti

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Similar Trials

Study of ABT-301 With Tislelizumab and Bevacizumab in pMMR/N...

Colorectal Cancer (Diagnosis)

Actively Recruiting

15 locations

Can Needle Size Improve Cancer Detection Rate of Transperine...

Prostate Cancer Diagnosis

Actively Recruiting

1 location

The PROACT LUNG Study: Observational Clinical Validation of ...

Lung Cancer Diagnosis

Actively Recruiting

36 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here